PGEYX
Price
$27.10
Change
+$0.09 (+0.33%)
Updated
Jul 17 closing price
Net Assets
2.19B
RLBCX
Price
$36.65
Change
+$0.09 (+0.25%)
Updated
Jul 17 closing price
Net Assets
251.77B
Interact to see
Advertisement

PGEYX vs RLBCX

Header iconPGEYX vs RLBCX Comparison
Open Charts PGEYX vs RLBCXBanner chart's image
George Putnam Balanced Y
Price$27.10
Change+$0.09 (+0.33%)
VolumeN/A
Net Assets2.19B
American Funds American Balanced R3
Price$36.65
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets251.77B
PGEYX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGEYX vs. RLBCX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEYX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. PGEYX (2.19B). PGEYX pays higher dividends than RLBCX: PGEYX (1.69) vs RLBCX (1.57). PGEYX was incepted earlier than RLBCX: PGEYX (31 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PGEYX (0.68). PGEYX is a more actively managed with annual turnover of: 80.00 vs. RLBCX (44.00). PGEYX has a lower initial minimum investment than RLBCX: PGEYX (0) vs RLBCX (250). RLBCX (6.69) and PGEYX (6.42) have marching annual gain over last year. RLBCX return over 5 years is better than : 37.12 vs. PGEYX (33.36).
PGEYXRLBCXPGEYX / RLBCX
Total Expense Ratio0.680.8976%
Annual Report Gross Expense Ratio0.680.8976%
Fund Existence31 years23 years-
Gain YTD5.4577.94669%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B252B1%
Annual Yield % from dividends1.691.57108%
Returns for 1 year6.426.6996%
Returns for 3 years41.4334.94119%
Returns for 5 years33.3637.1290%
Returns for 10 years79.6659.39134%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WINT1.050.15
+16.67%
Windtree Therapeutics Inc.
LOOP1.310.08
+6.50%
Loop Industries
STLD131.153.68
+2.89%
Steel Dynamics
TSHA2.590.05
+1.97%
Taysha Gene Therapies
ADNT22.05-0.33
-1.47%
Adient plc